Trial Review

Did you know?

The ANZCTR now automatically displays published trial results and simplifies the addition of trial documents such as unpublished protocols and statistical analysis plans.

These enhancements will offer a more comprehensive view of trials, regardless of whether their results are positive, negative, or inconclusive.

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this information for consumers
Trial details imported from ClinicalTrials.gov

For full trial details, please see the original record at https://clinicaltrials.gov/study/NCT01272713




Registration number
NCT01272713
Ethics application status
Date submitted
22/12/2010
Date registered
10/01/2011
Date last updated
7/05/2014

Titles & IDs
Public title
Air Verses Oxygen In myocarDial Infarction Study
Scientific title
A Randomised Controlled Trial of Oxygen Therapy in Acute Myocardial Infarction (AVOID - Air Verses Oxygen In myocarDial Infarction Study)
Secondary ID [1] 0 0
HREC/10/ALFRED/52
Universal Trial Number (UTN)
Trial acronym
AVOID
Linked study record

Health condition
Health condition(s) or problem(s) studied:
Acute Myocardial Infarction 0 0
Coronary Artery Disease 0 0
Condition category
Condition code
Cardiovascular 0 0 0 0
Coronary heart disease
Cardiovascular 0 0 0 0
Other cardiovascular diseases

Intervention/exposure
Study type
Interventional
Description of intervention(s) / exposure
Other interventions - Oxygen therapy
Other interventions - No oxygen therapy

Other: Oxygen therapy - * Standard acute coronary syndrome treatment as per hospital protocol
* Pre-hospital supplemental oxygen administered via Hudson mask at a flow rate of 8L/min
* In-hospital oxygen as per hospital protocol

Other: No oxygen therapy - * Standard acute coronary syndrome treatment as per hospital protocol
* No oxygen pre-hospital or in-hospital unless the oxygen saturation falls below 94% in which case oxygen will be administered via nasal cannulae (4L/min) or Hudson mask (8L/min) and titrated to achieve oxygen saturation of 94%.


Other interventions: Oxygen therapy
* Pre-hospital supplemental oxygen administered via Hudson mask at a flow rate of 8L/min
* In-hospital oxygen as per hospital protocol

Other interventions: No oxygen therapy
No oxygen pre-hospital or in-hospital unless the oxygen saturation falls below 94% in which case oxygen will be administered via nasal cannulae (4L/min) or Hudson mask (8L/min) and titrated to achieve oxygen saturation of 94%.
Intervention code [1] 0 0
Other interventions
Comparator / control treatment
Control group

Outcomes
Primary outcome [1] 0 0
Myocardial Infarct Size
Timepoint [1] 0 0
At 72 hours post infarct
Secondary outcome [1] 0 0
ST segment resolution
Timepoint [1] 0 0
1 day post reperfusion
Secondary outcome [2] 0 0
TIMI Flow
Timepoint [2] 0 0
At completion of coronary intervention procedure
Secondary outcome [3] 0 0
Survival to Hospital Discharge
Timepoint [3] 0 0
Any
Secondary outcome [4] 0 0
Major Adverse Cardiac Events (MACE)
Timepoint [4] 0 0
6 months
Secondary outcome [5] 0 0
Myocardial Salvage
Timepoint [5] 0 0
4 days and 6 months

Eligibility
Key inclusion criteria
* Adults = 18 years of age.
* Chest pain for < 12 hours
* ST-elevation Myocardial Infarction including either: 1) Persistent ST-segment elevation of =1mm in two contiguous limb leads; 2) ST-segment elevation of = 2mm in two contiguous chest leads, or; 3) New left bundle branch block (LBBB) pattern.
* Able to be transported to a participating hospital
Minimum age
18 Years
Maximum age
No limit
Sex
Both males and females
Can healthy volunteers participate?
No
Key exclusion criteria
* Hypoxia with oxygen saturation measured on pulse oximeter < 94% with the patient breathing air
* Bronchospasm requiring nebulised salbutamol therapy using oxygen
* Altered conscious state

Study design
Purpose of the study
Treatment
Allocation to intervention
Randomised controlled trial
Procedure for enrolling a subject and allocating the treatment (allocation concealment procedures)
Methods used to generate the sequence in which subjects will be randomised (sequence generation)
Masking / blinding
Blinded (masking used)
Who is / are masked / blinded?


The people assessing the outcomes
Intervention assignment
Parallel
Other design features
Phase
NA
Type of endpoint/s
Statistical methods / analysis

Recruitment
Recruitment status
UNKNOWN
Data analysis
Reason for early stopping/withdrawal
Other reasons
Date of first participant enrolment
Anticipated
Actual
1/10/2011
Date of last participant enrolment
Anticipated
Actual
Date of last data collection
Anticipated
1/08/2014
Actual
Sample size
Target
Accrual to date
Final
638
Recruitment in Australia
Recruitment state(s)
VIC
Recruitment hospital [1] 0 0
Peninsula Private Hospital - Frankston
Recruitment hospital [2] 0 0
Alfred Hospital - Melbourne
Recruitment hospital [3] 0 0
Western Hospital - Melbourne
Recruitment hospital [4] 0 0
Royal Melbourne Hospital - Melbourne
Recruitment hospital [5] 0 0
St Vincents Hospital - Melbourne
Recruitment hospital [6] 0 0
Austin Hospital - Melbourne
Recruitment hospital [7] 0 0
Ambulance Victoria - Melbourne
Recruitment hospital [8] 0 0
Box Hill Hospital - Melbourne
Recruitment hospital [9] 0 0
Monash Medical Centre - Melbourne
Recruitment hospital [10] 0 0
Frankston Hospital - Melbourne
Recruitment postcode(s) [1] 0 0
3199 - Frankston
Recruitment postcode(s) [2] 0 0
3004 - Melbourne
Recruitment postcode(s) [3] 0 0
3011 - Melbourne
Recruitment postcode(s) [4] 0 0
3053 - Melbourne
Recruitment postcode(s) [5] 0 0
3065 - Melbourne
Recruitment postcode(s) [6] 0 0
3084 - Melbourne
Recruitment postcode(s) [7] 0 0
3108 - Melbourne
Recruitment postcode(s) [8] 0 0
3128 - Melbourne
Recruitment postcode(s) [9] 0 0
3168 - Melbourne
Recruitment postcode(s) [10] 0 0
3199 - Melbourne

Funding & Sponsors
Primary sponsor type
Government body
Name
Bayside Health
Address
Country
Other collaborator category [1] 0 0
Government body
Name [1] 0 0
Ambulance Victoria
Address [1] 0 0
Country [1] 0 0
Other collaborator category [2] 0 0
Other
Name [2] 0 0
Monash University
Address [2] 0 0
Country [2] 0 0
Other collaborator category [3] 0 0
Other
Name [3] 0 0
Baker Heart and Diabetes Institute
Address [3] 0 0
Country [3] 0 0
Other collaborator category [4] 0 0
Other
Name [4] 0 0
FALCK Foundation
Address [4] 0 0
Country [4] 0 0

Ethics approval
Ethics application status

Summary
Brief summary
Trial website
Trial related presentations / publications
Public notes

Contacts
Principal investigator
Name 0 0
Stephen Bernard, MBBS MD
Address 0 0
Alfred Hospital, Monash University, Ambulance Victoria
Country 0 0
Phone 0 0
Fax 0 0
Email 0 0
Contact person for public queries
Name 0 0
Address 0 0
Country 0 0
Phone 0 0
Fax 0 0
Email 0 0
Contact person for scientific queries

No information has been provided regarding IPD availability


What supporting documents are/will be available?

No Supporting Document Provided



Results publications and other study-related documents

No documents have been uploaded by study researchers.

Results not provided in https://clinicaltrials.gov/study/NCT01272713